Calendar iBio, Inc.

Equities

IBIO

US4510337086

Market Closed - Nyse 01:40:00 27/04/2024 am IST 5-day change 1st Jan Change
1.76 USD +2.33% Intraday chart for iBio, Inc. +2.33% +28.47%

Chart calendar iBio, Inc.

972f.w8WQfZ0Ky4CiDTpSqspp8Q6hFYPfw7iOhce9bNho2uo.iZCpJO9epcuUTnEQ3Jg_sk3ZQtqRot789YT6KKgNiYySoNxI2jygsutHUQ~704ae852e48a74faa3e86c0ee03bdb56

Upcoming events on iBio, Inc.

10/05/2024 Q3 2024 Earnings Release (Projected)
24/09/2024 Q4 2024 Earnings Release (Projected)

Past events on iBio, Inc.

27/03/2024 06:00 pm Business Update Call
17/01/2024 06:45 am PepTalk Conference
29/11/2023 Reverse Split: 1 of 20
28/11/2023 02:30 am Annual General Meeting
12/10/2023 03:50 pm Biologics Festival - Enhancing Bispecific T Cell Engager Discovery
10/10/2023 05:50 pm Biologics Festival - Pitfalls to Avoid When Building an AI-Driven Platform Company
28/09/2023 01:49 am Q4 2023 Earnings Release
16/05/2023 09:30 pm JMP Securities Life Sciences Conference - Fireside Chat
07/12/2022 11:50 pm JMP Securities Hematology and Oncology Summit
04/12/2022 Antibody Engineering & Therapeutics Conference - Epitope-Targeted
04/12/2022 Antibody Engineering & Therapeutics Conference - Fully Human & Developable Antibody
10/10/2022 Reverse Split: 1 of 25
28/09/2022 02:00 am FY 2022 Earnings Call
28/09/2022 01:40 am FY 2022 Earnings Release
30/06/2022 07:00 pm Extraordinary Shareholders Meeting
24/05/2022 H.C. Wainwright Global Life Sciences Investment Conference
13/05/2022 02:00 am Q3 2022 Earnings Call
13/05/2022 01:35 am Q3 2022 Earnings Release
02/05/2022 Protein & Antibody Engineering Summit Boston Conference & Expo
18/03/2022 12:10 am Oppenheimer Healthcare Conference

Annual results

Fiscal PeriodJune 2019 2020 2021 2022 2023
Net sales
Million USD
Released
Forecast
Spread
2,02


1,64
0,60
173%
2,37
2,60
-8.81%
2,38
2,50
-4.68%
0,39
0,50
-21.8%
EBITDA
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread
0,00


-14,0
-15,9
11.93%
-31,1
-29,5
-5.46%
-49,7
-43,2
-15.02%
0,00
0,00
-
Earnings before Tax (EBT)
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
Net income
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
EPS
USD
Released
Forecast
Spread
-470


0,00
0,00
-
0,00
0,00
-
-116
-115
-0.52%
0,00
0,00
-
Announcement Date26/08/1913/10/2027/09/2111/10/2227/09/23

Quarterly results

Fiscal PeriodJune 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q2
Net sales
Million USD
Released
Forecast
Spread
0,17
0,25
-32.8%
1,94
0,20
871.5%
0,06
0,20
-69.5%
0,00
0,60
-
0,13
0,60
-78.33%
0,21
0,20
2.5%
0,00
0,20
-
0,00


EBIT
Million USD
Released
Forecast
Spread
-11,6
-9,56
-21.72%
-12,2
-11,4
-6.86%
-16,9
-12,2
-38.49%
-7,64
-17,9
57.34%
-10,6
-6,80
-55.49%









Net income
Million USD
Released
Forecast
Spread
-11,9
-9,53
-25.34%





















EPS
USD
Released
Forecast
Spread
-25,0
-20,0
-25%
-30,0
-30,0
0%
-113
-40,0
-181.5%
-41,0
-35,0
-17.14%









-4,42


Announcement Date14/02/2212/05/2211/10/2214/11/2214/02/2315/05/2327/09/2315/02/24

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise